Regenxbio Inc (RGNX) — Cash Flow-to-Debt Ratio
Regenxbio Inc (RGNX) has a Cash Flow-to-Debt Ratio of -0.20x as of June 2026, meaning its operating cash flow of $-62.24 Million could theoretically repay 0% of its total liabilities ($314.85 Million) in one year. See RGNX financial flexibility score to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Regenxbio Inc Cash Flow-to-Debt Ratio (2013–2025)
Historical debt coverage capacity for Regenxbio Inc across 13 annual periods. For the full cash flow conversion analysis, see cash efficiency ratio of Regenxbio Inc.
Annual Cash Flow-to-Debt Ratio for Regenxbio Inc (2013–2025)
Year-by-year debt coverage analysis for Regenxbio Inc. Check RGNX cash to earnings ratio to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.35x | $-123.96 Million | $350.30 Million | ▲ +57.8% |
| 2024 | -0.84x | $-173.12 Million | $206.34 Million | ▼ -0.7% |
| 2023 | -0.83x | $-218.41 Million | $262.23 Million | ▼ -27.3% |
| 2022 | -0.65x | $-207.49 Million | $317.07 Million | ▼ -204.5% |
| 2021 | 0.63x | $218.88 Million | $349.61 Million | ▲ +482.6% |
| 2020 | -0.16x | $-54.06 Million | $330.41 Million | ▲ +92.8% |
| 2019 | -2.26x | $-107.70 Million | $47.71 Million | ▼ -175.4% |
| 2018 | 2.99x | $104.65 Million | $34.97 Million | ▲ +180.8% |
| 2017 | -3.71x | $-57.99 Million | $15.65 Million | ▲ +16.1% |
| 2016 | -4.42x | $-48.56 Million | $10.99 Million | ▲ +10.3% |
| 2015 | -4.92x | $-22.52 Million | $4.57 Million | ▼ -1786.3% |
| 2014 | -0.26x | $-2.40 Million | $9.19 Million | ▲ +59.7% |
| 2013 | -0.65x | $-3.01 Million | $4.65 Million | — |